Courtesy of Donald E. Ingber, M.D., Ph.D.

Curiosity Expert: Donald E. Ingber, M.D., Ph.D.

Founding Director, Wyss Institute for Biologically Inspired Engineering, Harvard University; Professor of Bioengineering, Harvard School of Engineering and Applied Sciences

Donald E. Ingber, M.D., Ph.D., is the Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, Judah Folkman Professor of Vascular Biology at Harvard Medical School and Children's Hospital Boston, and Professor of Bioengineering at Harvard School of Engineering and Applied Sciences. He has made major contributions to cell and tissue engineering, microsystems engineering and nanobiotechnology, as well as cell biology, mechanotransduction, angiogenesis, and cancer research. His team strives to identify design principles that govern the formation and control of living systems, and to use this knowledge to develop novel therapeutics, nanomaterials and bioinspired microdevices. By combining approaches from molecular cell biology, chemistry, physics, engineering, computer science, magnetics, and optics, Ingber has helped to develop multiple new experimental nano- and micro-technologies, including human 'organs-on-chips,' as well as engineered tissues and cancer therapeutics that have entered human clinical trials. His contributions include more than 300 publications and 70 patents in areas ranging from anti-cancer therapeutics, tissue engineering, medical devices, organ chips and nanotechnology to bioinformatics software. Among his many awards and distinctions, Ingber received the Biomedical Engineering Society's Pritzker award, Rous Whipple Award of the American Association of Investigative Pathologists, Lifetime Achievement Award of the Society for In Vitro Biology, and the Holst Medal. He is also a recipient of a Breast Cancer Innovator Award from the Department of Defense, and a Fellow of the American Institute for Medical and Biological Engineering.

Comments
Comments

Comments ( )  

ADVERTISEMENT